Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Cytokinetics Company Profile (NASDAQ:CYTK)

Consensus Ratings for Cytokinetics (NASDAQ:CYTK) (?)
Ratings Breakdown: 2 Hold Rating(s), 5 Buy Rating(s)
Consensus Rating:Buy (Score: 2.71)
Consensus Price Target: $8.05 (96.82% upside)

Analysts' Ratings History for Cytokinetics (NASDAQ:CYTK)
Show:
DateFirmActionRatingPrice TargetDetailsShare
7/10/2014ZacksUpgradeNeutral -> Outperform$5.30ViewTweet This Rating  Share This Rating on StockTwits
7/10/2014Roth CapitalReiterated RatingBuyViewTweet This Rating  Share This Rating on StockTwits
5/19/2014Leerink SwannReiterated RatingOutperform$20.00 -> $8.00ViewTweet This Rating  Share This Rating on StockTwits
5/8/2014Canaccord GenuityReiterated RatingBuy$9.00 -> $8.00ViewTweet This Rating  Share This Rating on StockTwits
4/28/2014Canaccord GenuityReiterated RatingBuy$22.00 -> $9.00ViewTweet This Rating  Share This Rating on StockTwits
4/28/2014Needham & Company LLCLower Price TargetBuy$25.00 -> $15.00ViewTweet This Rating  Share This Rating on StockTwits
4/25/2014MLV & Co DowngradeBuy -> Hold$26.00 -> $5.00ViewTweet This Rating  Share This Rating on StockTwits
4/25/2014Piper JaffrayDowngradeOverweight -> Neutral$18.00 -> $7.00ViewTweet This Rating  Share This Rating on StockTwits
3/5/2014Roth CapitalInitiated CoverageBuy$25.00ViewTweet This Rating  Share This Rating on StockTwits
2/21/2014Piper JaffrayLower Price Target$24.00 -> $18.00ViewTweet This Rating  Share This Rating on StockTwits
10/11/2013Needham & Company LLCReiterated RatingBuyViewTweet This Rating  Share This Rating on StockTwits
9/3/2013Leerink SwannReiterated RatingIn-LineViewTweet This Rating  Share This Rating on StockTwits
7/17/2013Leerink SwannInitiated CoverageOutperformViewTweet This Rating  Share This Rating on StockTwits
6/26/2013Canaccord GenuityReiterated RatingBuyViewTweet This Rating  Share This Rating on StockTwits
6/26/2013MLV & Co Boost Price TargetBuy$24.00 -> $26.00ViewTweet This Rating  Share This Rating on StockTwits
6/13/2013Needham & Company LLCBoost Price TargetBuy$2.50 -> $3.50ViewTweet This Rating  Share This Rating on StockTwits
4/2/2013Needham & Company LLCReiterated RatingBuy$2.50ViewTweet This Rating  Share This Rating on StockTwits
1/3/2013Piper JaffrayInitiated CoverageOverweight$4.00ViewTweet This Rating  Share This Rating on StockTwits
11/27/2012Dawson JamesDowngradeOutperformViewTweet This Rating  Share This Rating on StockTwits
11/1/2012Canaccord GenuityReiterated RatingBuy -> BuyViewTweet This Rating  Share This Rating on StockTwits
8/1/2012Canaccord GenuityReiterated RatingBuyViewTweet This Rating  Share This Rating on StockTwits
8/1/2012Cowen and CompanyInitiated CoverageOutperformViewTweet This Rating  Share This Rating on StockTwits
7/31/2012Rodman & RenshawReiterated RatingOutperform$2.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 7/29/2012 forward)